Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
OC ›
OCTANATE
Trademark search for:
OCTANATE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-10-01 — Application filed
2014-12-18 — Sn assigned for sect 66a subseq desig from ib
2014-12-24 — Application filed
2014-12-30 — Application filed
2015-01-21 — Assigned to examiner
2015-01-26 — Final disposition recorded
2015-01-27 — Office action issued
2015-01-27 — Office action issued
2015-01-27 — Office action issued
2015-02-19 — Office action issued
2015-04-29 — Teas/email correspondence entered
2015-04-29 — Office action issued
2015-04-29 — Correspondence received in law office
2015-04-30 — Examiners amendment mailed
2015-04-30 — Examiners amendment -written
2015-04-30 — Approved for pub - principal register
2015-04-30 — Examiner's amendment entered
2015-05-26 — Assigned to lie
2015-05-26 — Law office publication review completed
2015-06-10 — Notification of notice of publication e-mailed
2015-06-24 — Notification of possible opposition sent to ib
2015-06-24 — Notice of start of opposition period created, to be sent to ib
2015-06-30 — Published for opposition
2015-06-30 — Official gazette publication confirmation e-mailed
2015-07-11 — Notification processed by ib
2015-09-15 — Registered-principal register
2015-12-15 — Final disposition recorded
2016-03-22 — Final disposition recorded
2016-03-22 — Final disposition recorded
2016-06-17 — Final disposition recorded
2016-08-11 — New representative at ib received
2016-08-11 — New representative at ib received
2016-08-18 — New representative at ib received
2017-12-02 — Final status recorded
2018-06-15 — Death of international registration
2018-06-15 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Octapharma AG
CH
Octapharma AG
CH
Octapharma AG
CH
Correspondent
Lawrence E. Abelman Abelman Frayne & Schwab 666 Third Avenue 10th Floor New York, NY 10017
Filing Details
Filing Date:
2014-10-01
Status Date:
2017-12-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.